Clinical characteristics of 182 pediatric COVID‐19 patients with different severities and allergic status
Background The pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has made widespread impact recently. We aim to investigate the clinical characteristics of COVID‐19 children with different severities and allergic status....
Uloženo v:
| Vydáno v: | Allergy (Copenhagen) Ročník 76; číslo 2; s. 510 - 532 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Denmark
Blackwell Publishing Ltd
01.02.2021
John Wiley and Sons Inc |
| Témata: | |
| ISSN: | 0105-4538, 1398-9995, 1398-9995 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background
The pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has made widespread impact recently. We aim to investigate the clinical characteristics of COVID‐19 children with different severities and allergic status.
Methods
Data extracted from the electronic medical records, including demographics, clinical manifestations, comorbidities, laboratory and immunological results, and radiological images of 182 hospitalized COVID‐19 children, were summarized and analyzed.
Results
The median age was 6 years, ranging from 3 days to 15 years, and there were more boys (male‐female ratio about 2:1) within the studied 182 patients. Most of the children were infected by family members. Fever (43.4%) and dry cough (44.5%) were common symptoms, and gastrointestinal manifestations accounted for 11.0%, including diarrhea, abdominal discomfort, and vomiting. 71.4% had abnormal chest computed tomography (CT) scan images, and typical signs of pneumonia were ground‐glass opacity and local patchy shadowing on admission. Laboratory results were mostly within normal ranges, and only a small ratio of lymphopenia (3.9%) and eosinopenia (29.5%) were observed. The majority (97.8%) of infected children were not severe, and 24 (13.2%) of them had asymptomatic infections. Compared to children without pneumonia (manifested as asymptomatic and acute upper respiratory infection), children with pneumonia were associated with higher percentages of the comorbidity history, symptoms of fever and cough, and increased levels of serum procalcitonin, alkaline phosphatase, and serum interleukins (IL)‐2, IL‐4, IL‐6, IL‐10, and TNF‐α. There were no differences in treatments, duration of hospitalization, time from first positive to first negative nucleic acid testing, and outcomes between children with mild pneumonia and without pneumonia. All the hospitalized COVID‐19 children had recovered except one death due to intussusception and sepsis. In 43 allergic children with COVID‐19, allergic rhinitis (83.7%) was the major disease, followed by drug allergy, atopic dermatitis, food allergy, and asthma. Demographics and clinical features were not significantly different between allergic and nonallergic groups. Allergic patients showed less increase in acute phase reactants, procalcitonin, D‐dimer, and aspartate aminotransferase levels compared with all patients. Immunological profiles including circulating T, B, and NK lymphocyte subsets, total immunoglobulin and complement levels, and serum cytokines did not show any difference in allergic and pneumonia groups. Neither eosinophil counts nor serum total immunoglobulin E (IgE) levels showed a significant correlation with other immunological measures, such as other immunoglobulins, complements, lymphocyte subset numbers, and serum cytokine levels.
Conclusion
Pediatric COVID‐19 patients tended to have a mild clinical course. Patients with pneumonia had higher proportion of fever and cough and increased inflammatory biomarkers than those without pneumonia. There was no difference between allergic and nonallergic COVID‐19 children in disease incidence, clinical features, and laboratory and immunological findings. Allergy was not a risk factor for developing and severity of SARS‐CoV‐2 infection and hardly influenced the disease course of COVID‐19 in children.
There is no difference between allergic and nonallergic children in clinical features and laboratory/immunological findings, and allergy is not a risk factor for COVID‐19. The majority (97.8%) of infected children were not severe, and 24 (13.2%) of them had asymptomatic infections. Laboratory results were mostly within normal ranges, and only a small ratio of lymphopenia (3.9%) and eosinopenia (29.5%) was observed. Higher proportion of patients with pneumonia have fever, cough, comorbidities, and increased inflammatory biomarkers (procalcitonin, alkaline phosphatase and serum interleukins (IL)‐2, IL‐4, IL‐6, IL‐10, and TNF‐α) than those without pneumonia. Abbreviations: AD, atopic dermatitis; AR, allergic rhinitis; AST, aspartate aminotransferase, AURI, acute upper respiratory infection; COVID‐19, coronavirus disease 2019; DA, drug allergy; FA, food allergy; PCT, procalcitonin; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; TNF, tumor necrosis factor. |
|---|---|
| AbstractList | BackgroundThe pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has made widespread impact recently. We aim to investigate the clinical characteristics of COVID‐19 children with different severities and allergic status.MethodsData extracted from the electronic medical records, including demographics, clinical manifestations, comorbidities, laboratory and immunological results, and radiological images of 182 hospitalized COVID‐19 children, were summarized and analyzed.ResultsThe median age was 6 years, ranging from 3 days to 15 years, and there were more boys (male‐female ratio about 2:1) within the studied 182 patients. Most of the children were infected by family members. Fever (43.4%) and dry cough (44.5%) were common symptoms, and gastrointestinal manifestations accounted for 11.0%, including diarrhea, abdominal discomfort, and vomiting. 71.4% had abnormal chest computed tomography (CT) scan images, and typical signs of pneumonia were ground‐glass opacity and local patchy shadowing on admission. Laboratory results were mostly within normal ranges, and only a small ratio of lymphopenia (3.9%) and eosinopenia (29.5%) were observed. The majority (97.8%) of infected children were not severe, and 24 (13.2%) of them had asymptomatic infections. Compared to children without pneumonia (manifested as asymptomatic and acute upper respiratory infection), children with pneumonia were associated with higher percentages of the comorbidity history, symptoms of fever and cough, and increased levels of serum procalcitonin, alkaline phosphatase, and serum interleukins (IL)‐2, IL‐4, IL‐6, IL‐10, and TNF‐α. There were no differences in treatments, duration of hospitalization, time from first positive to first negative nucleic acid testing, and outcomes between children with mild pneumonia and without pneumonia. All the hospitalized COVID‐19 children had recovered except one death due to intussusception and sepsis. In 43 allergic children with COVID‐19, allergic rhinitis (83.7%) was the major disease, followed by drug allergy, atopic dermatitis, food allergy, and asthma. Demographics and clinical features were not significantly different between allergic and nonallergic groups. Allergic patients showed less increase in acute phase reactants, procalcitonin, D‐dimer, and aspartate aminotransferase levels compared with all patients. Immunological profiles including circulating T, B, and NK lymphocyte subsets, total immunoglobulin and complement levels, and serum cytokines did not show any difference in allergic and pneumonia groups. Neither eosinophil counts nor serum total immunoglobulin E (IgE) levels showed a significant correlation with other immunological measures, such as other immunoglobulins, complements, lymphocyte subset numbers, and serum cytokine levels.ConclusionPediatric COVID‐19 patients tended to have a mild clinical course. Patients with pneumonia had higher proportion of fever and cough and increased inflammatory biomarkers than those without pneumonia. There was no difference between allergic and nonallergic COVID‐19 children in disease incidence, clinical features, and laboratory and immunological findings. Allergy was not a risk factor for developing and severity of SARS‐CoV‐2 infection and hardly influenced the disease course of COVID‐19 in children. Background The pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has made widespread impact recently. We aim to investigate the clinical characteristics of COVID‐19 children with different severities and allergic status. Methods Data extracted from the electronic medical records, including demographics, clinical manifestations, comorbidities, laboratory and immunological results, and radiological images of 182 hospitalized COVID‐19 children, were summarized and analyzed. Results The median age was 6 years, ranging from 3 days to 15 years, and there were more boys (male‐female ratio about 2:1) within the studied 182 patients. Most of the children were infected by family members. Fever (43.4%) and dry cough (44.5%) were common symptoms, and gastrointestinal manifestations accounted for 11.0%, including diarrhea, abdominal discomfort, and vomiting. 71.4% had abnormal chest computed tomography (CT) scan images, and typical signs of pneumonia were ground‐glass opacity and local patchy shadowing on admission. Laboratory results were mostly within normal ranges, and only a small ratio of lymphopenia (3.9%) and eosinopenia (29.5%) were observed. The majority (97.8%) of infected children were not severe, and 24 (13.2%) of them had asymptomatic infections. Compared to children without pneumonia (manifested as asymptomatic and acute upper respiratory infection), children with pneumonia were associated with higher percentages of the comorbidity history, symptoms of fever and cough, and increased levels of serum procalcitonin, alkaline phosphatase, and serum interleukins (IL)‐2, IL‐4, IL‐6, IL‐10, and TNF‐α. There were no differences in treatments, duration of hospitalization, time from first positive to first negative nucleic acid testing, and outcomes between children with mild pneumonia and without pneumonia. All the hospitalized COVID‐19 children had recovered except one death due to intussusception and sepsis. In 43 allergic children with COVID‐19, allergic rhinitis (83.7%) was the major disease, followed by drug allergy, atopic dermatitis, food allergy, and asthma. Demographics and clinical features were not significantly different between allergic and nonallergic groups. Allergic patients showed less increase in acute phase reactants, procalcitonin, D‐dimer, and aspartate aminotransferase levels compared with all patients. Immunological profiles including circulating T, B, and NK lymphocyte subsets, total immunoglobulin and complement levels, and serum cytokines did not show any difference in allergic and pneumonia groups. Neither eosinophil counts nor serum total immunoglobulin E (IgE) levels showed a significant correlation with other immunological measures, such as other immunoglobulins, complements, lymphocyte subset numbers, and serum cytokine levels. Conclusion Pediatric COVID‐19 patients tended to have a mild clinical course. Patients with pneumonia had higher proportion of fever and cough and increased inflammatory biomarkers than those without pneumonia. There was no difference between allergic and nonallergic COVID‐19 children in disease incidence, clinical features, and laboratory and immunological findings. Allergy was not a risk factor for developing and severity of SARS‐CoV‐2 infection and hardly influenced the disease course of COVID‐19 in children. There is no difference between allergic and nonallergic children in clinical features and laboratory/immunological findings, and allergy is not a risk factor for COVID‐19. The majority (97.8%) of infected children were not severe, and 24 (13.2%) of them had asymptomatic infections. Laboratory results were mostly within normal ranges, and only a small ratio of lymphopenia (3.9%) and eosinopenia (29.5%) was observed. Higher proportion of patients with pneumonia have fever, cough, comorbidities, and increased inflammatory biomarkers (procalcitonin, alkaline phosphatase and serum interleukins (IL)‐2, IL‐4, IL‐6, IL‐10, and TNF‐α) than those without pneumonia. Abbreviations: AD, atopic dermatitis; AR, allergic rhinitis; AST, aspartate aminotransferase, AURI, acute upper respiratory infection; COVID‐19, coronavirus disease 2019; DA, drug allergy; FA, food allergy; PCT, procalcitonin; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; TNF, tumor necrosis factor. There is no difference between allergic and nonallergic children in clinical features and laboratory/immunological findings, and allergy is not a risk factor for COVID‐19. The majority (97.8%) of infected children were not severe, and 24 (13.2%) of them had asymptomatic infections. Laboratory results were mostly within normal ranges, and only a small ratio of lymphopenia (3.9%) and eosinopenia (29.5%) was observed. Higher proportion of patients with pneumonia have fever, cough, comorbidities, and increased inflammatory biomarkers (procalcitonin, alkaline phosphatase and serum interleukins (IL)‐2, IL‐4, IL‐6, IL‐10, and TNF‐α) than those without pneumonia. Abbreviations: AD, atopic dermatitis; AR, allergic rhinitis; AST, aspartate aminotransferase, AURI, acute upper respiratory infection; COVID‐19, coronavirus disease 2019; DA, drug allergy; FA, food allergy; PCT, procalcitonin; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; TNF, tumor necrosis factor. The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has made widespread impact recently. We aim to investigate the clinical characteristics of COVID-19 children with different severities and allergic status.BACKGROUNDThe pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has made widespread impact recently. We aim to investigate the clinical characteristics of COVID-19 children with different severities and allergic status.Data extracted from the electronic medical records, including demographics, clinical manifestations, comorbidities, laboratory and immunological results, and radiological images of 182 hospitalized COVID-19 children, were summarized and analyzed.METHODSData extracted from the electronic medical records, including demographics, clinical manifestations, comorbidities, laboratory and immunological results, and radiological images of 182 hospitalized COVID-19 children, were summarized and analyzed.The median age was 6 years, ranging from 3 days to 15 years, and there were more boys (male-female ratio about 2:1) within the studied 182 patients. Most of the children were infected by family members. Fever (43.4%) and dry cough (44.5%) were common symptoms, and gastrointestinal manifestations accounted for 11.0%, including diarrhea, abdominal discomfort, and vomiting. 71.4% had abnormal chest computed tomography (CT) scan images, and typical signs of pneumonia were ground-glass opacity and local patchy shadowing on admission. Laboratory results were mostly within normal ranges, and only a small ratio of lymphopenia (3.9%) and eosinopenia (29.5%) were observed. The majority (97.8%) of infected children were not severe, and 24 (13.2%) of them had asymptomatic infections. Compared to children without pneumonia (manifested as asymptomatic and acute upper respiratory infection), children with pneumonia were associated with higher percentages of the comorbidity history, symptoms of fever and cough, and increased levels of serum procalcitonin, alkaline phosphatase, and serum interleukins (IL)-2, IL-4, IL-6, IL-10, and TNF-α. There were no differences in treatments, duration of hospitalization, time from first positive to first negative nucleic acid testing, and outcomes between children with mild pneumonia and without pneumonia. All the hospitalized COVID-19 children had recovered except one death due to intussusception and sepsis. In 43 allergic children with COVID-19, allergic rhinitis (83.7%) was the major disease, followed by drug allergy, atopic dermatitis, food allergy, and asthma. Demographics and clinical features were not significantly different between allergic and nonallergic groups. Allergic patients showed less increase in acute phase reactants, procalcitonin, D-dimer, and aspartate aminotransferase levels compared with all patients. Immunological profiles including circulating T, B, and NK lymphocyte subsets, total immunoglobulin and complement levels, and serum cytokines did not show any difference in allergic and pneumonia groups. Neither eosinophil counts nor serum total immunoglobulin E (IgE) levels showed a significant correlation with other immunological measures, such as other immunoglobulins, complements, lymphocyte subset numbers, and serum cytokine levels.RESULTSThe median age was 6 years, ranging from 3 days to 15 years, and there were more boys (male-female ratio about 2:1) within the studied 182 patients. Most of the children were infected by family members. Fever (43.4%) and dry cough (44.5%) were common symptoms, and gastrointestinal manifestations accounted for 11.0%, including diarrhea, abdominal discomfort, and vomiting. 71.4% had abnormal chest computed tomography (CT) scan images, and typical signs of pneumonia were ground-glass opacity and local patchy shadowing on admission. Laboratory results were mostly within normal ranges, and only a small ratio of lymphopenia (3.9%) and eosinopenia (29.5%) were observed. The majority (97.8%) of infected children were not severe, and 24 (13.2%) of them had asymptomatic infections. Compared to children without pneumonia (manifested as asymptomatic and acute upper respiratory infection), children with pneumonia were associated with higher percentages of the comorbidity history, symptoms of fever and cough, and increased levels of serum procalcitonin, alkaline phosphatase, and serum interleukins (IL)-2, IL-4, IL-6, IL-10, and TNF-α. There were no differences in treatments, duration of hospitalization, time from first positive to first negative nucleic acid testing, and outcomes between children with mild pneumonia and without pneumonia. All the hospitalized COVID-19 children had recovered except one death due to intussusception and sepsis. In 43 allergic children with COVID-19, allergic rhinitis (83.7%) was the major disease, followed by drug allergy, atopic dermatitis, food allergy, and asthma. Demographics and clinical features were not significantly different between allergic and nonallergic groups. Allergic patients showed less increase in acute phase reactants, procalcitonin, D-dimer, and aspartate aminotransferase levels compared with all patients. Immunological profiles including circulating T, B, and NK lymphocyte subsets, total immunoglobulin and complement levels, and serum cytokines did not show any difference in allergic and pneumonia groups. Neither eosinophil counts nor serum total immunoglobulin E (IgE) levels showed a significant correlation with other immunological measures, such as other immunoglobulins, complements, lymphocyte subset numbers, and serum cytokine levels.Pediatric COVID-19 patients tended to have a mild clinical course. Patients with pneumonia had higher proportion of fever and cough and increased inflammatory biomarkers than those without pneumonia. There was no difference between allergic and nonallergic COVID-19 children in disease incidence, clinical features, and laboratory and immunological findings. Allergy was not a risk factor for developing and severity of SARS-CoV-2 infection and hardly influenced the disease course of COVID-19 in children.CONCLUSIONPediatric COVID-19 patients tended to have a mild clinical course. Patients with pneumonia had higher proportion of fever and cough and increased inflammatory biomarkers than those without pneumonia. There was no difference between allergic and nonallergic COVID-19 children in disease incidence, clinical features, and laboratory and immunological findings. Allergy was not a risk factor for developing and severity of SARS-CoV-2 infection and hardly influenced the disease course of COVID-19 in children. The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has made widespread impact recently. We aim to investigate the clinical characteristics of COVID-19 children with different severities and allergic status. Data extracted from the electronic medical records, including demographics, clinical manifestations, comorbidities, laboratory and immunological results, and radiological images of 182 hospitalized COVID-19 children, were summarized and analyzed. The median age was 6 years, ranging from 3 days to 15 years, and there were more boys (male-female ratio about 2:1) within the studied 182 patients. Most of the children were infected by family members. Fever (43.4%) and dry cough (44.5%) were common symptoms, and gastrointestinal manifestations accounted for 11.0%, including diarrhea, abdominal discomfort, and vomiting. 71.4% had abnormal chest computed tomography (CT) scan images, and typical signs of pneumonia were ground-glass opacity and local patchy shadowing on admission. Laboratory results were mostly within normal ranges, and only a small ratio of lymphopenia (3.9%) and eosinopenia (29.5%) were observed. The majority (97.8%) of infected children were not severe, and 24 (13.2%) of them had asymptomatic infections. Compared to children without pneumonia (manifested as asymptomatic and acute upper respiratory infection), children with pneumonia were associated with higher percentages of the comorbidity history, symptoms of fever and cough, and increased levels of serum procalcitonin, alkaline phosphatase, and serum interleukins (IL)-2, IL-4, IL-6, IL-10, and TNF-α. There were no differences in treatments, duration of hospitalization, time from first positive to first negative nucleic acid testing, and outcomes between children with mild pneumonia and without pneumonia. All the hospitalized COVID-19 children had recovered except one death due to intussusception and sepsis. In 43 allergic children with COVID-19, allergic rhinitis (83.7%) was the major disease, followed by drug allergy, atopic dermatitis, food allergy, and asthma. Demographics and clinical features were not significantly different between allergic and nonallergic groups. Allergic patients showed less increase in acute phase reactants, procalcitonin, D-dimer, and aspartate aminotransferase levels compared with all patients. Immunological profiles including circulating T, B, and NK lymphocyte subsets, total immunoglobulin and complement levels, and serum cytokines did not show any difference in allergic and pneumonia groups. Neither eosinophil counts nor serum total immunoglobulin E (IgE) levels showed a significant correlation with other immunological measures, such as other immunoglobulins, complements, lymphocyte subset numbers, and serum cytokine levels. Pediatric COVID-19 patients tended to have a mild clinical course. Patients with pneumonia had higher proportion of fever and cough and increased inflammatory biomarkers than those without pneumonia. There was no difference between allergic and nonallergic COVID-19 children in disease incidence, clinical features, and laboratory and immunological findings. Allergy was not a risk factor for developing and severity of SARS-CoV-2 infection and hardly influenced the disease course of COVID-19 in children. |
| Author | Akdis, Mubeccel Akdis, Cezmi A. Chen, Hong‐wei Lu, Xiao‐xia Li, Ying Zhang, Jin‐jin Liu, Guang‐hui Huang, Pei‐qi Cao, Yi‐yuan Du, Hui Gao, Ya‐dong Dong, Xiang |
| AuthorAffiliation | 2 Department of Allergology Zhongnan Hospital of Wuhan University Wuhan China 3 Department of Radiology Zhongnan Hospital of Wuhan University Wuhan China 4 Swiss Institute of Allergy and Asthma Research (SIAF) University of Zurich Davos Switzerland 1 Department of Respiratory Medicine Wuhan Children’s Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China |
| AuthorAffiliation_xml | – name: 1 Department of Respiratory Medicine Wuhan Children’s Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China – name: 4 Swiss Institute of Allergy and Asthma Research (SIAF) University of Zurich Davos Switzerland – name: 2 Department of Allergology Zhongnan Hospital of Wuhan University Wuhan China – name: 3 Department of Radiology Zhongnan Hospital of Wuhan University Wuhan China |
| Author_xml | – sequence: 1 givenname: Hui surname: Du fullname: Du, Hui organization: Huazhong University of Science and Technology – sequence: 2 givenname: Xiang orcidid: 0000-0002-5241-4307 surname: Dong fullname: Dong, Xiang organization: Zhongnan Hospital of Wuhan University – sequence: 3 givenname: Jin‐jin orcidid: 0000-0002-4414-866X surname: Zhang fullname: Zhang, Jin‐jin organization: Zhongnan Hospital of Wuhan University – sequence: 4 givenname: Yi‐yuan surname: Cao fullname: Cao, Yi‐yuan organization: Zhongnan Hospital of Wuhan University – sequence: 5 givenname: Mubeccel orcidid: 0000-0003-0554-9943 surname: Akdis fullname: Akdis, Mubeccel organization: University of Zurich – sequence: 6 givenname: Pei‐qi surname: Huang fullname: Huang, Pei‐qi organization: Huazhong University of Science and Technology – sequence: 7 givenname: Hong‐wei surname: Chen fullname: Chen, Hong‐wei organization: Huazhong University of Science and Technology – sequence: 8 givenname: Ying surname: Li fullname: Li, Ying organization: Huazhong University of Science and Technology – sequence: 9 givenname: Guang‐hui surname: Liu fullname: Liu, Guang‐hui organization: Zhongnan Hospital of Wuhan University – sequence: 10 givenname: Cezmi A. orcidid: 0000-0001-8020-019X surname: Akdis fullname: Akdis, Cezmi A. email: akdisca@siaf.uzh.ch organization: University of Zurich – sequence: 11 givenname: Xiao‐xia surname: Lu fullname: Lu, Xiao‐xia email: akdisca@siaf.uzh.ch, xueboen007@163.com, gaoyadong@whu.edu.cn organization: Huazhong University of Science and Technology – sequence: 12 givenname: Ya‐dong orcidid: 0000-0003-1251-7608 surname: Gao fullname: Gao, Ya‐dong email: gaoyadong@whu.edu.cn organization: Zhongnan Hospital of Wuhan University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32524611$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc1u1DAUhS1URKctC14AWWJTFmn9FyfeIFUDhUojdQPdWo5z03HxxIPttOqOR-AZeZJ6mCmCCryxrPudo-NzD9DeGEZA6BUlJ7ScU-P9CRWiZs_QjHLVVkqpeg_NCCV1JWre7qODlG4IIQ1T5AXa56xmQlI6Q1_n3o3OGo_t0kRjM0SXsrMJhwHTluE19M7k6CyeX15dvP_5_QdVeG2ygzEnfOfyEvduGCCWN05wW_RllrAZe1xyQbwu0pRNntIRej4Yn-Dl7j5EX84_fJ5_qhaXHy_mZ4vKCsFZ1TR9ZxltWCeFMbLlQJpeUZBda6QE0tXd0DMBtQAw1FrDKe9bLhsFqmNK8UP0buu7nroV9LYki8brdXQrE-91ME7_PRndUl-HW91w0lBGisHxziCGbxOkrFcuWfDejBCmpJmgjFEppSjomyfoTZjiWL5XKEVEabneGL7-M9HvKI97KMDpFrAxpBRh0NaVzlzYBHReU6I3m9alUf1r00Xx9oni0fRf7M79znm4_z-ozxaLreIBNIa5BA |
| CitedBy_id | crossref_primary_10_1055_s_0044_1778699 crossref_primary_10_1002_ppul_26403 crossref_primary_10_1016_j_msard_2021_103363 crossref_primary_10_3390_ijms24065870 crossref_primary_10_31083_j_fbl2707204 crossref_primary_10_1111_all_15058 crossref_primary_10_1111_all_15454 crossref_primary_10_3390_jcm11205987 crossref_primary_10_1111_all_16028 crossref_primary_10_1111_all_16149 crossref_primary_10_5812_icrj_161434 crossref_primary_10_3390_children9111745 crossref_primary_10_4103_njcp_njcp_359_22 crossref_primary_10_3389_fped_2021_617980 crossref_primary_10_1111_cea_14023 crossref_primary_10_1097_MCO_0000000000000825 crossref_primary_10_3390_ijerph191811483 crossref_primary_10_1016_j_tim_2022_12_008 crossref_primary_10_3390_nu13113689 crossref_primary_10_3389_fimmu_2023_1284047 crossref_primary_10_7759_cureus_60069 crossref_primary_10_1016_j_it_2020_12_002 crossref_primary_10_1038_s41598_020_75659_5 crossref_primary_10_3389_fped_2020_563093 crossref_primary_10_3390_medicina59101765 crossref_primary_10_1016_j_jhazmat_2025_137940 crossref_primary_10_1111_all_14496 crossref_primary_10_1111_all_14657 crossref_primary_10_1155_2021_6706218 crossref_primary_10_1136_bmjresp_2021_001038 crossref_primary_10_1186_s12876_022_02132_0 crossref_primary_10_1002_lio2_1012 crossref_primary_10_2500_aap_2024_45_230087 crossref_primary_10_1186_s13052_021_01198_y crossref_primary_10_3390_su142215171 crossref_primary_10_1007_s12519_021_00480_7 crossref_primary_10_1016_j_rmed_2025_108125 crossref_primary_10_1093_intimm_dxab107 crossref_primary_10_1590_0037_8682_0714_2020 crossref_primary_10_2500_aap_2021_42_210087 crossref_primary_10_3389_fimmu_2022_988479 crossref_primary_10_2147_JAA_S402674 crossref_primary_10_1093_tropej_fmab051 crossref_primary_10_1002_clt2_12330 crossref_primary_10_3389_fpsyt_2021_761968 crossref_primary_10_1186_s12879_020_05730_z crossref_primary_10_3389_fimmu_2022_848961 crossref_primary_10_1186_s12879_023_08291_z crossref_primary_10_1111_bjh_17014 crossref_primary_10_3389_fbuil_2021_641745 crossref_primary_10_1093_jpids_piae052 crossref_primary_10_7189_jogh_14_05003 crossref_primary_10_1016_j_cytogfr_2022_01_001 crossref_primary_10_1055_s_0043_1769902 crossref_primary_10_1038_s41467_022_30357_w crossref_primary_10_1007_s12519_021_00424_1 crossref_primary_10_1016_j_numecd_2021_04_012 crossref_primary_10_1002_rmv_2316 crossref_primary_10_1002_pbc_28975 crossref_primary_10_1038_s41598_021_92500_9 crossref_primary_10_1002_alr_23090 crossref_primary_10_1111_crj_13813 crossref_primary_10_1111_pedi_13402 crossref_primary_10_1111_all_14449 crossref_primary_10_1016_j_ijregi_2023_05_001 crossref_primary_10_1111_all_14608 crossref_primary_10_1038_s41598_024_78493_1 crossref_primary_10_3390_jcm11226772 crossref_primary_10_3390_v14102162 crossref_primary_10_9778_cmajo_20220072 crossref_primary_10_3389_fmolb_2021_708336 crossref_primary_10_1097_MD_0000000000025230 crossref_primary_10_4103_atm_atm_709_20 crossref_primary_10_1111_pai_13851 crossref_primary_10_1111_pai_13696 crossref_primary_10_1111_all_14972 crossref_primary_10_1002_hsr2_1226 crossref_primary_10_3390_ijerph18094781 crossref_primary_10_4254_wjh_v15_i3_353 crossref_primary_10_3389_fimmu_2021_723585 crossref_primary_10_1002_ped4_12283 crossref_primary_10_1097_MD_0000000000024897 crossref_primary_10_3889_oamjms_2022_8065 crossref_primary_10_1080_02770903_2023_2301426 crossref_primary_10_2147_IDR_S515224 crossref_primary_10_1097_ANA_0000000000000803 crossref_primary_10_1155_2022_5625104 crossref_primary_10_12956_tchd_1433881 crossref_primary_10_1155_2022_6510332 crossref_primary_10_1007_s10875_021_01066_8 crossref_primary_10_1002_clt2_12097 crossref_primary_10_1002_rcr2_1077 crossref_primary_10_15446_rsap_v22n6_91181 crossref_primary_10_1073_pnas_2109229118 crossref_primary_10_1007_s10620_021_07158_0 crossref_primary_10_1186_s43168_022_00110_4 crossref_primary_10_1017_S0022215122000536 crossref_primary_10_1111_all_14472 crossref_primary_10_1111_all_15044 crossref_primary_10_2147_JAA_S497018 crossref_primary_10_1016_j_anai_2020_11_021 crossref_primary_10_1111_pai_13757 crossref_primary_10_2147_IJGM_S374090 crossref_primary_10_2500_aap_2021_42_210059 crossref_primary_10_1097_MPH_0000000000002321 crossref_primary_10_1186_s43054_024_00341_8 crossref_primary_10_3390_jcm11175019 crossref_primary_10_1186_s43556_022_00077_0 |
| Cites_doi | 10.1001/jama.2020.2648 10.1016/j.jaci.2020.04.009 10.1007/s11596-020-2172-6 10.1007/s12519-020-00343-7 10.1038/s41591-020-0817-4 10.1055/s-0036-1584797 10.1111/all.14238 10.1016/j.scitotenv.2020.138812 10.1111/j.1398-9995.2010.02505.x 10.1001/jama.2020.3980 10.1038/s41586-020-2012-7 10.1093/infdis/jiaa150 10.3109/02770903.2015.1126848 10.1186/1939-4551-7-12 10.1016/j.jpeds.2020.05.007 10.1038/s41564-020-0695-z 10.1056/NEJMc2005073 10.1016/j.aller.2017.04.003 10.4168/aair.2019.11.2.156 10.1056/NEJMoa2001017 10.1111/pai.12819 10.15585/mmwr.mm6914e4 10.1016/S0140-6736(20)30566-3 10.1016/j.jinf.2020.03.054 10.1111/all.14309 10.1111/all.14047 10.1111/all.14172 10.3390/v10120682 10.1542/peds.2020-0702 10.15585/mmwr.mm6705e1 10.1007/s00330-020-06860-3 10.1016/S1473-3099(20)30198-5 10.1093/cid/ciaa198 10.5415/apallergy.2016.6.2.101 10.1111/all.14289 10.1016/S0140-6736(20)31094-1 10.1016/j.jpeds.2020.05.006 10.1016/S0140-6736(14)60615-2 10.1016/j.pedneo.2020.03.001 10.1016/j.jaci.2020.04.006 10.1111/pai.12318 10.1111/all.14302 |
| ContentType | Journal Article |
| Copyright | 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. 2021 EAACI and John Wiley and Sons A/S |
| Copyright_xml | – notice: 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. – notice: 2021 EAACI and John Wiley and Sons A/S |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 5PM |
| DOI | 10.1111/all.14452 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | DU et al |
| EISSN | 1398-9995 |
| EndPage | 532 |
| ExternalDocumentID | PMC7307120 32524611 10_1111_all_14452 ALL14452 |
| Genre | article Journal Article |
| GroupedDBID | .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 5PM |
| ID | FETCH-LOGICAL-c4432-77dbc2172b64aa683e07d91e6b8a66e0b5bfd24e54eea1cca313d83679e9b2993 |
| IEDL.DBID | WIN |
| ISICitedReferencesCount | 149 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000566362500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0105-4538 1398-9995 |
| IngestDate | Tue Nov 04 02:01:00 EST 2025 Wed Oct 01 14:13:16 EDT 2025 Mon Oct 06 17:21:17 EDT 2025 Thu Apr 03 06:56:36 EDT 2025 Sat Nov 29 06:24:58 EST 2025 Tue Nov 18 22:18:54 EST 2025 Wed Jan 22 16:29:58 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | COVID-19 lymphocyte subsets allergy SARS-CoV-2 pneumonia children |
| Language | English |
| License | 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4432-77dbc2172b64aa683e07d91e6b8a66e0b5bfd24e54eea1cca313d83679e9b2993 |
| Notes | Hui Du and Xiang Dong are contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-4414-866X 0000-0003-1251-7608 0000-0001-8020-019X 0000-0002-5241-4307 0000-0003-0554-9943 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7307120 |
| PMID | 32524611 |
| PQID | 2490446150 |
| PQPubID | 34098 |
| PageCount | 23 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7307120 proquest_miscellaneous_2412216664 proquest_journals_2490446150 pubmed_primary_32524611 crossref_citationtrail_10_1111_all_14452 crossref_primary_10_1111_all_14452 wiley_primary_10_1111_all_14452_ALL14452 |
| PublicationCentury | 2000 |
| PublicationDate | February 2021 |
| PublicationDateYYYYMMDD | 2021-02-01 |
| PublicationDate_xml | – month: 02 year: 2021 text: February 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Denmark |
| PublicationPlace_xml | – name: Denmark – name: Zurich – name: Hoboken |
| PublicationTitle | Allergy (Copenhagen) |
| PublicationTitleAlternate | Allergy |
| PublicationYear | 2021 |
| Publisher | Blackwell Publishing Ltd John Wiley and Sons Inc |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: John Wiley and Sons Inc |
| References | 2018; 29 2020; 20 2020; 382 2020; 40 2019; 11 2020; 61 2020; 81 2016; 53 2020; 16 2014; 25 2020; 58 2020; 35 2020; 145 2020; 221 2020; 323 2020; 146 2020; 223 2018; 67 2020; 728 2016; 37 2018; 46 2016; 6 2020; 5 2020; 75 2020; 30 2020 2020; 395 2013; 51 2020; 26 2011; 66 2020; 579 2020; 69 2014; 7 2018; 10 2014; 383 e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_39_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_42_1 e_1_2_9_20_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_21_1 e_1_2_9_46_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_23_1 e_1_2_9_44_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 Jiang Y (e_1_2_9_14_1) 2020; 35 e_1_2_9_5_1 e_1_2_9_4_1 National Cooperative Group on Childhood Asthma (e_1_2_9_40_1) 2013; 51 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_28_1 e_1_2_9_47_1 e_1_2_9_27_1 e_1_2_9_48_1 e_1_2_9_29_1 Chen F (e_1_2_9_25_1) 2020; 58 |
| References_xml | – volume: 6 start-page: 101 year: 2016 end-page: 104 article-title: Obesity is a risk factor for allergic rhinitis in children of Wuhan (China) publication-title: Asia Pac Allergy – volume: 26 start-page: 502 issue: 4 year: 2020 end-page: 505 article-title: Characteristics of pediatric SARS‐CoV‐2 infection and potential evidence for persistent fecal viral shedding publication-title: Nat Med – volume: 58 start-page: 179 year: 2020 end-page: 182 article-title: First case of severe childhood novel coronavirus pneumonia in China publication-title: Zhonghua Er Ke Za Zhi – volume: 146 start-page: 203 issue: 1 year: 2020 end-page: 206 article-title: Association of respiratory allergy, asthma, and expression of the SARS‐CoV‐2 receptor ACE2 publication-title: J Allergy Clin Immunol – volume: 382 start-page: 727 year: 2020 end-page: 733 article-title: A novel coronavirus from patients with pneumonia in China, 2019 publication-title: N Engl J Med – volume: 221 start-page: 1762 issue: 11 year: 2020 end-page: 1769 article-title: Characteristics of peripheral lymphocyte subset alteration in COVID‐19 pneumonia publication-title: J Infect Dis – volume: 395 start-page: 1607 issue: 10237 year: 2020 end-page: 1608 article-title: Hyperinflammatory shock in children during COVID‐19 pandemic publication-title: Lancet – volume: 728 start-page: 138812 year: 2020 article-title: Factors associated with negative conversion of viral RNA in patients hospitalized with COVID‐19 publication-title: Sci Total Environ – volume: 323 start-page: 1256 issue: 13 year: 2020 article-title: Editorial concern‐possible reporting of the same patients with COVID‐19 in different reports publication-title: JAMA – volume: 5 start-page: 536 year: 2020 end-page: 544 article-title: The species Severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2 publication-title: Nat Microbiol – volume: 29 start-page: 127 year: 2018 end-page: 132 article-title: Pediatric allergy and immunology in China publication-title: Pediatr Allergy Immunol – volume: 67 start-page: 149 year: 2018 end-page: 155 article-title: Vital Signs: Asthma in Children ‐ United States, 2001–2016 publication-title: MMWR Morb Mortal Wkly Rep – volume: 75 start-page: 1730 issue: 7 year: 2020 end-page: 1741 article-title: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China publication-title: Allergy – volume: 146 start-page: 110 issue: 1 year: 2020 end-page: 118 article-title: Risk factors for severity and mortality in adult COVID‐19 inpatients in Wuhan publication-title: J Allergy Clin Immunol – volume: 7 start-page: 12 year: 2014 article-title: Allergic diseases and asthma: a global public health concern and a call to action publication-title: World Allergy Organ J – volume: 323 start-page: 1239 issue: 13 year: 2020 article-title: Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID‐19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention publication-title: JAMA – volume: 75 start-page: 576 issue: 3 year: 2020 end-page: 587 article-title: Pollen exposure weakens innate defense against respiratory viruses publication-title: Allergy – volume: 30 start-page: 4427 issue: 8 year: 2020 end-page: 4433 article-title: CT features of novel coronavirus pneumonia (COVID‐19) in children publication-title: Eur Radiol – volume: 145 issue: 6 year: 2020 article-title: Epidemiology of COVID‐19 among children in china publication-title: Pediatrics – volume: 25 start-page: 796 year: 2014 end-page: 803 article-title: The first wheezing episode: respiratory virus etiology, atopic characteristics, and illness severity publication-title: Pediatr Allergy Immunol – volume: 223 start-page: 14 year: 2020 end-page: 19 article-title: Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City publication-title: J Pediatr – volume: 51 start-page: 729 year: 2013 end-page: 735 article-title: [Third nationwide survey of childhood asthma in urban areas of China] publication-title: Zhonghua Er Ke Za Zhi – volume: 81 start-page: 318 issue: 2 year: 2020 end-page: 356 article-title: Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID‐19 publication-title: J Infect – volume: 69 start-page: 422 issue: 14 year: 2020 end-page: 426 article-title: Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020 publication-title: MMWR Morb Mortal Wkly Rep – volume: 75 start-page: 2440 year: 2020 end-page: 2444 article-title: Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement publication-title: Allergy – volume: 579 start-page: 270 year: 2020 end-page: 273 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature – volume: 35 start-page: 143 issue: 2 year: 2020 end-page: 150 article-title: [Expert consensus on the diagnosis, treatment and prevention of SARS‐CoV‐2 infection in children (2nd Version)] publication-title: Chin J Appl Clin Pediatr – volume: 75 start-page: 1742 issue: 7 year: 2020 end-page: 1752 article-title: COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China publication-title: Allergy – volume: 395 start-page: 1054 issue: 10229 year: 2020 end-page: 1062 article-title: Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study publication-title: Lancet – volume: 11 start-page: 156 year: 2019 end-page: 169 article-title: Increasing prevalence of allergic rhinitis in China publication-title: Allergy Asthma Immunol Res – volume: 75 start-page: 2711 year: 2020 end-page: 2712 article-title: Medical algorithm: Diagnosis and treatment of preschool asthma publication-title: Allergy – volume: 37 start-page: 555 year: 2016 end-page: 571 article-title: Update on human rhinovirus and coronavirus infections publication-title: Semin Respir Crit Care Med – volume: 53 start-page: 356 year: 2016 end-page: 362 article-title: Trends in allergy prevalence among children aged 0–17 years by asthma status, United States, 2001–2013 publication-title: J Asthma – volume: 382 start-page: 1663 issue: 17 year: 2020 end-page: 1665 article-title: SARS‐CoV‐2 Infection in Children publication-title: N Engl J Med – volume: 61 start-page: 131 issue: 2 year: 2020 end-page: 132 article-title: Clinical characteristics of novel coronavirus disease 2019 (COVID‐19) in newborns, infants and children publication-title: Pediatr Neonatol – volume: 40 start-page: 1 year: 2020 end-page: 6 article-title: Clinical characteristics of children with coronavirus disease 2019 in Hubei publication-title: China. Curr Med Sci – year: 2020 article-title: A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features publication-title: Clin Infect Dis – volume: 10 start-page: 682 issue: 12 year: 2018 article-title: Small animal models of respiratory viral infection related to asthma publication-title: Viruses – volume: 223 start-page: 199 year: 2020 end-page: 203 article-title: Severe Coronavirus Disease‐2019 in Children and Young Adults in the Washington, DC, Metropolitan Region publication-title: J Pediatr – volume: 20 start-page: 689 issue: 6 year: 2020 end-page: 696 article-title: Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID‐19) in Zhejiang, China: an observational cohort study publication-title: Lancet Infect Dis – volume: 383 start-page: 1593 year: 2014 end-page: 1604 article-title: Diagnosis, management, and prognosis of preschool wheeze publication-title: Lancet – volume: 66 start-page: 458 year: 2011 end-page: 468 article-title: Viruses and bacteria in acute asthma exacerbations–a GA LEN‐DARE systematic review publication-title: Allergy – volume: 46 start-page: 119 year: 2018 end-page: 126 article-title: Does atopy affect the course of viral pneumonia publication-title: Allergol Immunopathol (Madr) – volume: 75 start-page: 1699 issue: 7 year: 2020 end-page: 1709 article-title: Eleven faces of coronavirus disease 2019 publication-title: Allergy – volume: 16 start-page: 223 issue: 3 year: 2020 end-page: 231 article-title: Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement publication-title: World J Pediatr – ident: e_1_2_9_8_1 doi: 10.1001/jama.2020.2648 – ident: e_1_2_9_34_1 doi: 10.1016/j.jaci.2020.04.009 – ident: e_1_2_9_26_1 doi: 10.1007/s11596-020-2172-6 – ident: e_1_2_9_48_1 doi: 10.1007/s12519-020-00343-7 – ident: e_1_2_9_11_1 doi: 10.1038/s41591-020-0817-4 – ident: e_1_2_9_20_1 doi: 10.1055/s-0036-1584797 – ident: e_1_2_9_23_1 doi: 10.1111/all.14238 – ident: e_1_2_9_49_1 doi: 10.1016/j.scitotenv.2020.138812 – ident: e_1_2_9_6_1 – ident: e_1_2_9_19_1 doi: 10.1111/j.1398-9995.2010.02505.x – volume: 51 start-page: 729 year: 2013 ident: e_1_2_9_40_1 article-title: [Third nationwide survey of childhood asthma in urban areas of China] publication-title: Zhonghua Er Ke Za Zhi – volume: 35 start-page: 143 issue: 2 year: 2020 ident: e_1_2_9_14_1 article-title: [Expert consensus on the diagnosis, treatment and prevention of SARS‐CoV‐2 infection in children (2nd Version)] publication-title: Chin J Appl Clin Pediatr – ident: e_1_2_9_24_1 doi: 10.1001/jama.2020.3980 – ident: e_1_2_9_7_1 – ident: e_1_2_9_4_1 doi: 10.1038/s41586-020-2012-7 – ident: e_1_2_9_44_1 doi: 10.1093/infdis/jiaa150 – ident: e_1_2_9_16_1 doi: 10.3109/02770903.2015.1126848 – ident: e_1_2_9_15_1 doi: 10.1186/1939-4551-7-12 – ident: e_1_2_9_37_1 doi: 10.1016/j.jpeds.2020.05.007 – ident: e_1_2_9_5_1 doi: 10.1038/s41564-020-0695-z – ident: e_1_2_9_9_1 doi: 10.1056/NEJMc2005073 – ident: e_1_2_9_22_1 doi: 10.1016/j.aller.2017.04.003 – ident: e_1_2_9_31_1 doi: 10.4168/aair.2019.11.2.156 – ident: e_1_2_9_2_1 – ident: e_1_2_9_3_1 doi: 10.1056/NEJMoa2001017 – ident: e_1_2_9_17_1 doi: 10.1111/pai.12819 – ident: e_1_2_9_27_1 doi: 10.15585/mmwr.mm6914e4 – ident: e_1_2_9_41_1 doi: 10.1016/S0140-6736(20)30566-3 – ident: e_1_2_9_45_1 doi: 10.1016/j.jinf.2020.03.054 – volume: 58 start-page: 179 year: 2020 ident: e_1_2_9_25_1 article-title: First case of severe childhood novel coronavirus pneumonia in China publication-title: Zhonghua Er Ke Za Zhi – ident: e_1_2_9_43_1 doi: 10.1111/all.14309 – ident: e_1_2_9_18_1 doi: 10.1111/all.14047 – ident: e_1_2_9_36_1 doi: 10.1111/all.14172 – ident: e_1_2_9_21_1 doi: 10.3390/v10120682 – ident: e_1_2_9_28_1 doi: 10.1542/peds.2020-0702 – ident: e_1_2_9_39_1 doi: 10.15585/mmwr.mm6705e1 – ident: e_1_2_9_46_1 doi: 10.1007/s00330-020-06860-3 – ident: e_1_2_9_12_1 doi: 10.1016/S1473-3099(20)30198-5 – ident: e_1_2_9_10_1 doi: 10.1093/cid/ciaa198 – ident: e_1_2_9_30_1 doi: 10.5415/apallergy.2016.6.2.101 – ident: e_1_2_9_13_1 doi: 10.1111/all.14289 – ident: e_1_2_9_42_1 doi: 10.1016/S0140-6736(20)31094-1 – ident: e_1_2_9_38_1 doi: 10.1016/j.jpeds.2020.05.006 – ident: e_1_2_9_35_1 doi: 10.1016/S0140-6736(14)60615-2 – ident: e_1_2_9_29_1 doi: 10.1016/j.pedneo.2020.03.001 – ident: e_1_2_9_33_1 doi: 10.1016/j.jaci.2020.04.006 – ident: e_1_2_9_47_1 doi: 10.1111/pai.12318 – ident: e_1_2_9_32_1 doi: 10.1111/all.14302 |
| SSID | ssj0007290 |
| Score | 2.643804 |
| Snippet | Background
The pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has made... The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has made widespread impact... BackgroundThe pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has made... There is no difference between allergic and nonallergic children in clinical features and laboratory/immunological findings, and allergy is not a risk factor... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 510 |
| SubjectTerms | Adolescent Alkaline phosphatase Allergic rhinitis allergy Aspartate aminotransferase Asthma Asymptomatic Atopic dermatitis Child Child, Preschool Children Computed tomography Coronaviridae Coronaviruses Cough COVID-19 COVID-19 - complications COVID-19 - immunology COVID-19 - pathology Demography Diarrhea Electronic medical records Eosinopenia Female Fever Food allergies Humans Hypersensitivity - epidemiology Immunoglobulin E Immunoglobulins Immunology Incidence Infant Infant, Newborn Infections Inflammation Interleukins Intussusception Laboratories Leukocytes (eosinophilic) lymphocyte subsets Lymphocytes B Lymphopenia Male Original ORIGINAL ARTICLES Pandemics Patients Pediatrics Pneumonia Pneumonia, Viral - immunology Pneumonia, Viral - pathology SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Vomiting |
| Title | Clinical characteristics of 182 pediatric COVID‐19 patients with different severities and allergic status |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.14452 https://www.ncbi.nlm.nih.gov/pubmed/32524611 https://www.proquest.com/docview/2490446150 https://www.proquest.com/docview/2412216664 https://pubmed.ncbi.nlm.nih.gov/PMC7307120 |
| Volume | 76 |
| WOSCitedRecordID | wos000566362500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1398-9995 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007290 issn: 0105-4538 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1398-9995 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007290 issn: 0105-4538 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9tAEB7StJRekr7rJDXb0kMuAq80epFTSGIacN1SmtY3sY8xDTVysOye-xPyG_tLurNeiZikUOhNsCO0aOebmd2Z_QbgHQ10brJCRiUNMEKyGBUmkREhk5WhRGOsbzaRj8fFZFJ-2oKj9i7Mmh-iO3BjZHh7zQBXurkBcjWbcWYyZfsr0YPy2_m4s8J5OF9x8UOEDtWBVYireLo3N33RrQDzdp3kzfjVO6Dh7n9N_THshLhTHK8V5QlsUf0UHn4ImfVn8CMQhM6E2aRwFvOpcLsDcdX29BAnH7-en_7-dS1LEVhZG8HHuaJttrIUzt3SwnO1ClVbwf1aFs7ECr6-tGqew8Xw7MvJ-yg0YogMYsIRuNWGO1npDJXKioQGuS0lZbpQWeaWO9VTGyOlSKSk04lEJrZIsrykUjt_l7yA7Xpe0ysQBgdaGYVK2ymqlFRcaiXJkC0NX97qwWG7JJUJLOXcLGNWtbsVN-XK_7wevO1Er9bUHHcJHbTrWgV0NpXbcnIe28XCPXjTDTtccbJE1TRfsYyMY86pYg9ertWg-0oSp0zD5yabbyhIJ8Cc3Zsj9eV3z93tDGouY_fdQ68gf594dTwa-Ye9fxfdh0cxl9z4ovID2F4uVvQaHpify8tm0Yd7-aTow_3Tz8OLUd-j5Q_VKhf6 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LaxRBEC7CRjQX4ztrorbiIZeB7ZmeF3gJiUuCk1UkkdyGftRicJkN-_Ccn5Df6C-xqrdnyBIFwdtA1zDFdL26qvorgPc4MLnNChmVOFCRQqeiwiYyQsVgZUoqa50fNpGPRsXFRfllAz60d2FW-BBdwo01w9trVnBOSN_Scj2ZcGkyJQO8qUiM0h5sHn0dnledJc5DjoViiEiRZgdkIe7k6V5e90d3gsy7vZK3Y1jvhIbb_8f-I3gYgk9xsJKWx7CBzRO4fxrK60_hR0AJnQi7juMspmNBRwRx1Q72EIefv50c_bq-kaUI0KxzwTld0U5cWQjyuTjzgK1CN07w0JYZ2VnBd5iW82dwPvx4dngchWkMkVUq4TDcGcvjrEymtM6KBAe5KyVmptBZRnuemrGLFaYKUUsSjEQmrkiyvMTSkNNLnkOvmTa4A8KqgdFWK23cWOkUdVwaLdGiKy3f4OrDfrsntQ1Q5TwxY1K3RxZiufY_rw_vOtKrFT7Hn4j22o2tg4rOazp3cjGbAuI-vO2WSbm4YqIbnC6ZRsYxF1ZVH16s5KD7ShKnjMVHzOZrEtIRMHD3-kpz-d0DeJNVzWVM3933EvJ3xuuDqvIPL_-d9A08OD47rerqZPRpF7Zi7sHxXeZ70FvMlvgK7tmfi8v57HVQl99EFBq- |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LaxRBEC5CIsFLfOtq1FY85DKwPdPzaPASsi4G1zWIkdyGftRicJld9pGzP8Hf6C-xqrdnyBIFwdtA1zDNdH1V1V3VXwG8wb4tXVHJRGNfJQq9SiqXyQQVk5UpqZzzodlEOR5XFxf6bAfetndhNvwQ3YEbIyPYawY4zv3kGsrNdMqpyZwM8J7KdUGw3Bt8Hp6POktcxjMWiiESRciOzEJcydO9vO2PbgSZN2slr8ewwQkN7_zf9O_CQQw-xfFGW-7BDjb3Yf9jTK8_gO-RJXQq3DaPs5hNBG0RxLxt7CFOPn09Hfz68VNqEalZl4LPdEXbcWUlyOfiIhC2CtN4wU1bFmRnBd9hWi8fwvnw3ZeT90nsxpA4pTIOw7113M7KFsqYosqwX3otsbCVKQpa89xOfKowV4hGkmJkMvNVVpQatSWnlz2C3WbW4BMQTvWtcUYZ6yfK5GhSbY1Eh147vsHVg6N2TWoXqcq5Y8a0brcsNOU6_LwevO5E5xt-jj8JHbYLW0eILmvad3IymwLiHrzqhglcnDExDc7WLCPTlBOrqgePN3rQfSVLc-bio8mWWxrSCTBx9_ZIc_ktEHiTVS1lSt89Chry94nXx6NReHj676IvYf9sMKxHp-MPz-B2yiU4ocj8EHZXizU-h1vuanW5XLyIaPkNqogaOQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+characteristics+of+182+pediatric+COVID%E2%80%9019+patients+with+different+severities+and+allergic+status&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Du%2C+Hui&rft.au=Dong%2C+Xiang&rft.au=Zhang%2C+Jin%E2%80%90jin&rft.au=Cao%2C+Yi%E2%80%90yuan&rft.date=2021-02-01&rft.issn=0105-4538&rft.eissn=1398-9995&rft.volume=76&rft.issue=2&rft.spage=510&rft.epage=532&rft_id=info:doi/10.1111%2Fall.14452&rft.externalDBID=10.1111%252Fall.14452&rft.externalDocID=ALL14452 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon |